OBJECTIVE: To study clinical, anthropometric and metabolic determinants of serum leptin concentrations in a series of patients with a wide range of obesity. SUBJECTS: 400 patients, 116 males and 284 females, aged 44 AE 12.3 years with body mass index (BMI) ranging from 31 to 82 kgam 2 (mean 41.4 AE 7.1). MEASUREMENTS: Energy intake by 7-day recall, resting energy expenditure (REE) by indirect calorimetry, body composition determined by bioelectrical impedance; C index, an anthropometric index of abdominal fat distribution, and waist ± hip ratio (WHR), blood glucose serum leptin concentrations, total cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, uric acid, and insulin concentrations HOMA IRI (homeostastis model assessment of insulin resistance index). RESULTS: Leptin concentrations were higher in obese than in normal subjects and in females than in males without differences between diabetic and non-diabetic patients; leptin concentrations were not related to age and showed a strong negative association with energy intake only in the group of women with BMI less than 40. Leptin concentrations showed a direct correlation with BMI and body fat values (expressed either as percentage of total body mass or absolute fat mass) independent of age and sex. After adjustment for fat mass, leptin values higher than predicted were found in women whereas concentrations lower than predicted were found predominantly in men. Leptin showed an inverse correlation with WHR and C-index, the latter persisting also after correction for gender and fat mass. REE, but not REEakg fat-free mass (FFM) was inversely related to leptin also after correction for sex and absolute fat mass. Leptin concentrations were directly associated with HOMA IRI, insulin and HDL cholesterol and inversely associated with triglycerides and uric acid. The relationship of leptin with HOMA IRI was still evident after adjusting for sex but was lost when absolute fat mass was added to the model; HDL cholesterol and triglycerides appeared to be variables independent of leptin concentrations even when both sex and fat mass were added to the model. CONCLUSIONS: In a large group of obese patients (half of whom had severe obesity, gender, BMI and fat mass accounted for the largest proportion of serum leptin concentrations variability. We found that in obese subjects there is an effect of fat distribution on leptin concentrations and that, after excluding variability due to absolute fat mass, patients with a greater amount of abdominal fat have relatively low leptin concentrations which in turn relates to a metabolic pro®le compatible with an increased cardiovascular risk. Women with milder obesity may retain some degree of control of food intake by leptin.
Introduction
After the discovery of leptin in 1994 1 efforts have been made to elucidate the pathophysiological role of this peptide in experimental animals and in humans;
2 ± 4 the availability of radio immunoassay (RIA) methods for this peptide hormone produced by adipose tissue have led to an impressive accumulation of clinical studies on the relationships between leptin and anthropometric, metabolic and hormonal parameters in physiological and pathological conditions. Serum concentrations are elevated in human obesity suggesting a condition of resistance to this peptide, which would normally be associated with reduced food intake. 5 There is general agreement that serum leptin concentrations correlate with body fat mass; however, this correlation accounts only partially for the variability in serum leptin concentrations. 6 ± 8 Attempts have been made to gain insight into the determinants of leptin concentrations, 9±12 and thus, into the pathophysiological meaning of leptin in human obesity. Results have been partially conicting with some of these inconsistencies possibly due to different ranges of patients' body mass index (BMI) and gender ratio in the different series. The aim of the present study was to re-evaluate, in a very large series of patients with severe obesity, several anthropometric and metabolic factors related with serum leptin concentrations and to test the hypothesis that leptin concentrations may be associated with factors other than the absolute amount of adipose tissue and gender, such as adipose tissue distribution (central vs peripheral), energy expenditure and possibly with metabolic risk factors for cardiovascular disease.
Patients and methods

Patients
We studied 400 obese patients (Table 1) , 116 males and 284 females, aged 44AE 12.3 y (mean s.d.; range 14 ± 84 y), with BMI ranging from 31±82 kgam 2 (mean 41.4AE 7.1) out of a larger series of patients admitted to the Division of Endocrinology and Metabolic Diseases of S. Giuseppe Hospital, Verbania, Italy, for diagnostic or therapeutic problems related to obesity and its complications. Patients with concomitant severe renal, hepatic or cardiac disease were excluded from the study; patients with¯uid overload according to vectorial analysis 13 were also excluded to minimise errors of bioelectrical impedance analysis (BIA) in estimating fat and fat free-mass in severe obesity. The study was approved by the Hospital Ethics Committee; the aim and the design of the study were explained to the patients who gave their written informed consent. Eighty-six patients had noninsulin-dependent diabetes mellitus NIDDM, which was well controlled (glycated haemoglobin 6.4 AE 1.6%) by diet alone or combined with oral hypoglycaemic agents; 10 of these patients were on lipid lowering therapy with either ®brates (n 6) or statins (n 4); none was taking beta blockers whereas eight patients were on hydrochlorothiazide 12.5 mgad. None, except the diabetic patients, was taking drugs interfering with glucose or lipid metabolism. All the patients had stable weight during the month prior to the study. To estimate their habitual caloric intake, all patients underwent a careful 7-day dietary recall carried out by trained dieticians according to a standardised interview technique (including the use of a food-frequency questionnaire and of an atlas for assessment of food-portion size and of snacks). As a proxy for evaluating dietary under-reporting, we compared the estimated caloric intake with the measured resting energy expenditure increased by a factor allowing for sedentary physical activity. We assumed that a negative difference between reported energy intake minus resting energy expenditure multiplied by 1.2 (as a cautious estimate of total energy expenditure) would express under-reporting.
The patients underwent a diagnostic protocol which included measurement of height, weight, abdominal and hip girth for determination of body mass index (BMI), waist ± hip ratio (WHR) and C-index 14 as well as evaluation of resting energy expenditure (REE) and body composition. Blood chemistry included total cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, uric acid, fasting blood glucose and insulin. Leptin concentrations were determined on a blood sample taken at 8.00 a.m. after an overnight fast.
Methods
Resting Energy expenditure (REE) was assessed by a computerised, open-circuit, indirect calorimetry system that measured resting oxygen uptake and resting carbon dioxide production using a ventilated Body composition, expressed as percentage of total body mass and as absolute (kilograms) fat free mass (FFM) and Fat Mass (FAT), was determined by BIA (101aS, Akern, Firenze, Italy), in the morning, after an overnight fast and after voiding. The two vector components resistance (R) and reactance (Xc) were recorded from single measurements: before each testing session, the external calibration of the instrument was checked with a calibration circuit of known impedance value. The mean coef®cient of variation was 1% for within-day and 3% for weekly intraindividual measurements in the steady state condition in either site and 2% for inter-operator variability. Total body water and FFM of subjects were derived from the equations by Lukaski et al. 15, 16 Body fat distribution was measured by WHR and by C-index, this latter being an anthropometric parameter believed to be a reliable index for the assessment of central fat distribution.
14 The asserted advantages of this index vs WHR are the following: (i) it has a theoretical (expected) range, (ii) it includes a built-in adjustment of waist circumference for height and weight, allowing direct comparisons of abdominal adiposity between individuals or even between populations, (iii) it does not require the hip circumference to assess fat distribution. It is calculated according to the formula C-index abdominal girtha0.109 p weightaheight.
The waist circumference was taken as the largest standing horizontal circumference between the ribs and the iliac crest; the hip circumference was taken as the largest standing horizontal circumference of the buttocks. Glucose, total cholesterol, HDL cholesterol, triglycerides and uric acid were measured by enzymatic methods; insulin was determined by immunoenzymatic method (Tosoh, Kyobashi Chuo-Ku, Tokio, Japan).
Serum leptin concentrations were measured by radioimmunoassay using reagents supplied by Linco Research Inc (St Louis, MO USA). In this assay, detection limit is 0.15 ngaml; the intra assay precision (% CV) is 2.2% (6 ngaml), 2.7% (25 ngaml), and 5.9% (62.8 ngaml); inter assay precision from 10 different runs of 3 patients serum samples was 4.3%, 4%, 6.9% at the concentration of 5.1, 21 and 56.2 ngaml respectively; in 32 lean subjects (BMI 18 ± 25 kgam 2 ) reference limits (2.5 ± 97.5 percentiles) were 0.98 ± 5.17 ngaml in men and 2.6 ± 17.4 ngaml in women.
Index of insulin resistance was calculated by the HOMA (Homeostasis Model Assessment) using fasting plasma insulin and blood glucose according to Matthews et al. 19 
Statistical analysis
Since leptin concentrations were not normally distributed, data were log transformed. The relationships between leptin and the other parameters were assessed by univariate regression analysis. To determine the independent effects of several variables, data were also analysed in stepwise multivariate analysis models with leptin as dependent variable. SPSS statistical software release 8.0 was used for statistical analysis whereas the regression lines were ®tted used the graphic Prism package release 2.01. Differences were accepted as signi®cant at P`0.05.
For simplicity data are presented as mean AE s.d. also for not normally distributed variables.
Results
In the whole group (Table 1) , mean basal leptin concentration was 43.3AE 24.5 ngaml (range 6.2 ± 169.4 ngaml). Women had signi®cantly higher (P`0.001) mean plasma leptin concentrations (51.1 AE 23.7 ngaml) than men (24.7 AE 13.3 ngaml) even after adjustment for kg of FAT; in either sex there were no age-related changes of leptin concentrations; in particular there were no differences in leptin concentrations between women of fertile (50.8AE 24.1 ngaml) or postmenopausal (51.1 AE 23.5 ngaml) age. Leptin values were no different in diabetic patients (39.13AE 23.18 ngaml) vs non-diabetic patients (43.6 AE 22.5 ngaml). Mean energy intake was 2821 AE 1335 kcalad in the whole group of patients; it was not related to leptin concentrations in the whole group of patients, but a negative ( 7 0.188; P`0.002) relation was evident when the data were analysed in the subgroup of patients with BMI below 40. This association persisted after adjusting for fat mass and fat distribution but not for gender; indeed only women showed the negative correlation between leptin and energy intake. There was no signi®cant difference in proportion of dietary underreporting between women and men (33% vs 27%) or between women with BMI`40 kgam 2 and those with BMI ! 40 kgam 2 (36% vs 31%). Table 2 reports the univariate coef®cients of correlation before and after adjusting for gender and FAT between serum leptin and the other parameters considered. The correlation between leptin and BMI, although very strong, also when patients were subgrouped according to gender, showed a very wide intersubject variability, similar leptin concentrations corresponding to markedly different BMI values ( Figure 1) ; for instance, patients with leptin values of 100 ngaml or higher could have a BMI ranging between 35 and 82.
Leptin showed a strong association with FAT, expressed either as percentage of total body composition or as absolute FAT. This relationship persisted
Leptin in obesity
A Liuzzi et al also after adjusting for age indicating that FAT is an independent determinant of leptin concentrations; the relationship between leptin and FAT was best described by an exponential function ( Figure 2 ).
When leptin values were adjusted for absolute fat mass and the actual and the corrected values were compared, leptin concentrations higher than expected (that is, two standard deviations of the mean of the differences) were found only in females, while lower than expected leptin values were found predominantly in males (Table 3) . Collectively, gender, BMI and percentage explained 55% of variability in leptin concentration.
The relation of leptin to fat distribution assessed by WHR or C-index ( Figure 3) showed an inverse association with both indices (r 2 7 0.02; P`0.004 and r 2 7 0.33`; P`0.001 respectively); however, the relation with WHR, but not with C-index (r 2 7 0.55; P`0.001), disappeared when the values were adjusted for gender and body fat mass; thus only C-index seems to be independently correlated with leptin concentrations.
REE, even when expressed for kg of FFM, correlated inversely with leptin values. REE, but not REEakg FFM, maintained its independent association with leptin concentrations also after adjusting for sex and kg of FAT.
Leptin concentrations were also directly associated with homeostasis model of insulin resistance index (HOMA IRI), fasting serum insulin, and HDL cholesterol and inversely associated with triglycerides and uric acid. The relationship of leptin with HOMA IRI was still apparent after correction for sex but was lost when kg of FAT was added to the model; HDL Leptin in obesity A Liuzzi et al cholesterol and triglycerides appeared to be positive and inverse independent correlates of leptin concentrations respectively even when both sex and FAT were added to the model. The results of multivariate analyses did not change when the presence or not of diabetes was introduced into the model and when patients on lipid lowering drugs or hydrochlorothiazide were excluded from the analysis.
Discussion
The results of our study, obtained in a large series of patients including only markedly obese subjects, half of whom had BMI b 40 kgam 2 , add valuable information to the issue of determinants of circulating leptin in relation to clinical, anthropometric and metabolic parameters.
Our data are in agreement with previous studies, performed on more restricted series including patients with only minor degrees of adiposity, concerning the ®nding of higher circulating concentrations of leptin in obese compared to normal subjects and in females 6, 8, 11, 12 than in males; it is of interest that the gender difference remains true also for very high levels of BMI, that is, between 50 and 80. Moreover, in both sexes of this group of exclusively obese patients with a wide age range, we could not con®rm age-related changes in leptin concentrations, as described in miscellaneous conditions including both overweight and normal weight subjects. 6, 18 In particular, women of fertile or postmenopausal age had similar leptin values. Thus, excess adiposity may prevent the decline in plasma leptin due to aging and estrogen de®ciency reported in non-obese subjects.
Leptin concentrations showed a high correlation with BMI and with FAT either expressed as percentage or as absolute FAT con®rming that the degree of adiposity is a major determinant of leptin concentration.
6 ± 8 However, sex, BMI and FAT together explained only 55% of serum leptin variability, con®rming that factors other than the absolute degree of adiposity are involved in controlling leptin production.
The observation that the relationship between leptin and percentage of body fat is best described by an exponential function, in accordance with the data by Ostlund et al, 6 indicates that above a certain threshold Figure 3 Simple regression between unadjusted serum leptin and C-index in 400 obese patients. Leptin in obesity A Liuzzi et al of adiposity, small increments of fatness may be accompanied by signi®cant increments of serum leptin. These ®ndings suggest that in situation of severe adiposity, fat cells secrete disproportionately amounts of leptin, which (as yet unidenti®ed) feedback mechanisms fail to respond to. A reduced clearance of leptin seems unlikely as a cause of the elevated plasma concentrations since the metabolic clearance rate of leptin has been found to be normal in patients with obesity. 19 More insight into this problem was gained when leptin concentrations were corrected for absolute FAT and actual and adjusted values were compared. Most of the patients showed leptin concentrations in accordance with their theoretical values, but about 30% had values lower or higher than those predicted by their adiposity (Table 3 ). In particular, leptin concentrations lower than expected were more often found in male subjects. A possible explanation for this observation may be the heterogeneity in leptin synthesis by adipose tissue as reported by Cinti et al. 20 Levels of leptin mRNA are lower in omental than in subcutaneous fat tissue 21, 22 and, more recently, van Harmelen et al 23 have provided evidence that subcutaneous tissue is two to three times more effective in synthesising leptin than omental tissue. Thus, patients with a relatively low plasma leptin concentration should be characterised by a higher visceral to subcutaneous fat ratio than those with relatively normal or high leptin values. The gender-related difference in plasma leptin, which cannot be fully accounted for by differences in the hormonal milieu, might indeed be explained by the presence of more abundant subcutaneous fat in women and of visceral fat in men. The relationship between circulating concentrations of leptin and fat distribution remains controversial: 24 ± 27 our data showed an inverse correlation between abdominal fat distribution, measured as waistahip ratio or Conicity-index and leptin, the latter association being independent of gender and a body fat. Conicityindex appears to have several theoretical advantages as a body fat distribution indicator compared to WHR; 16 thus, the prevalent abdominal fat distribution is a negative determinant of leptin concentrations independent of sex, a ®nding that suggests that a greater amount of visceral fat is associated with a relatively lower leptin value.
Exogenous leptin is known to increase thermogenesis 28 in rat brown adipose tissue. Con¯icting results have however been reported on the relationship between serum leptin concentrations and energy expenditure in humans, probably due to the heterogeneity of the patients studied; some studies reported a positive correlation between serum leptin and resting energy expenditure or 24-h energy expenditure 29 while others failed to show such a relation: 30, 31 Roberts et al 32 concluded that in normal weight adult humans, leptin does not in¯uence energy regulation through adaptive variations in energy expenditure. Rosenbaum et al 33 found, in a mixed series of 31 normal weight and 19 obese subjects, a trend towards a positive association between resting energy expenditure and leptin concentrations which disappeared when FAT and FFM were taken into account. Niskanen et al 34 found in a series of 45 obese subjects an inverse association Ð after correction for fat mass, age and sex Ð between leptin concentrations and resting energy expenditure, respiratory quotient and carbohydrate oxidation rate. In our large series of markedly obese subjects, leptin concentrations were independently related with resting energy expenditure in an inverse fashion, in accordance with the view that obesity is a condition of resistance to leptin. This correlation however was lost when the values of REE were expressed for kilogram of FFM suggesting that the resting thermogenesis of lean tissue is independent of leptin at least in obese subjects.
The ®nding of a negative correlation between leptin and energy intake, similar to that reported in healthy postmenopausal women, 35 only in females with BMI lower than 40, is unlikely to be accounted for by a lower reported caloric intake 36 ± 38 in our series of obese patients; there was no difference in the proportion of estimated dietary under-reporting in women with different degrees of obesity. A more convincing explanation could be the persistence of some feedback regulation of energy intake by circulating leptin in this group of less severe obese patients, possibly re¯ecting different degrees of leptin effect at the CNS level.
Con¯icting data also exist concerning the relationship between leptin, insulin and insulin sensitivity; our data showing that insulin is an independent correlate of leptin support the view that insulin has a stimulatory effect on leptin secretion, 39 ± 42 and is compatible with the demonstration that leptin has a facilitatory effect on insulin release. 43, 44 On the other hand, HOMA IRI, an index of insulin resistance, was no longer related to serum leptin after adjusting for FAT which in¯uences both leptin concentrations and insulin resistance; this seems to rule out a direct effect of leptin on plasma insulin; in other words the amount of FAT is the link between the elevated concentrations of leptin and the resistance to insulin in obesity.
Whether high leptin concentration is a facet of the metabolic syndrome and whether its measurement may be of value in identifying patients at risk of developing cardiovascular disease should also be considered. The data of our series show that plasma leptin is associated with serum HDL cholesterol, and inversely related to triglycerides, and uric acid. However, in a multivariate analysis, the only independent contributors to serum leptin were triglycerides and HDL, whereas uric acid was sex related and HOMA IRI was dependent on fat. These data suggest that, after accounting for absolute FAT mass, the lower the leptin concentration the higher the markers of cardiovascular risk; similar conclusions were reached by Leptin in obesity A Liuzzi et al Lonnqvist et al:
9 they stated that although leptin appeared not to be associated with the classical metabolic atherogenic complications of obesity, it might protect subjects with a gynoid fat distribution from metabolic complications.
In conclusion our study shows that in a large group of obese patients, half of whom had severe obesity, gender, BMI and FAT account for the largest proportion of variability of serum leptin concentrations. Our observation supports the view that in obese subjects there is an effect of fat distribution, as measured by Conicity index, on leptin concentrations and that, after excluding variability due to absolute FAT, patients with a greater amount of abdominal fat, as indicated by a higher Conicity index, have relatively low leptin values which in turn relate to a metabolic pro®le compatible with an increased cardiovascular risk. Lastly, the ®nding of an inverse relationship between serum leptin and energy intake only in women with milder obesity, even after correction for adiposity, is suggestive of the persistence of some degree of control of food intake by leptin in moderate human obesity.
